The leptomeningeal "ivy sign" on fluid-attenuated inversion recovery MR imaging in Moyamoya disease: A sign of decreased cerebral vascular reserve?

American Journal of Neuroradiology

Volumn 30, Issue 5, 2009, Pages 930-935

  Mori, Naoko ^a   Mugikura, S ^a   Higano, S ^a   Kaneta, T ^a   Fujimura, M ^a   Umetsu, A ^a   Murata, T ^a   Takahashi, S ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN ISCHEMIA; BRAIN REGION; CHILD; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HEMISPHERE; HUMAN; LEPTOMENINGEAL IVY SIGN; MALE; MEDICAL RECORD REVIEW; MIDDLE CEREBRAL ARTERY; MOYAMOYA DISEASE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SIGNAL DETECTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; ADULT; BRAIN ISCHEMIA; CEREBRAL ARTERIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MENINGEAL ARTERIES; MIDDLE AGED; MOYAMOYA DISEASE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 65949099334     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1504     Document Type: Article

References (24)

1. Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288-299
2. Maeda M, Tsuchida C. "Ivy sign" on fluid-attenuated inversion-recovery images in childhood moyamoya disease. AJNR Am J Neuroradiol 1999;20:1836-1838
3. Fujiwara H, Momoshima S, Kuribayashi S. Leptomeningeal high signal intensity (ivy sign) on fluid-attenuated inversion-recovery (FLAIR) MR images in moyamoya disease. Eur J Radiol 2005;55:224-230 (Pubitemid 40982440)
4. Fukui M. Annual Report 1993: The Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare. Tokyo: Ministry of Health and Welfare; 1994:122-124
5. Iida H, Itoh H, Nakazawa M, et al. Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT. J Nucl Med 1994;35:2019-2030 (Pubitemid 24376622)
6. Iida H, Akutsu T, Endo K, et al. A multicenter validation of regional cerebral blood flow quantitation using [123I]iodoamphetamine and single photon emission computed tomography. J Cereb Blood Flow Metab 1996;16:781-793 (Pubitemid 26292046)
7. Mugikura S, Takahashi S, Higano S, et al. The relationship between cerebral infarction and angiographic characteristics in childhood moyamoya disease. AJNR Am J Neuroradiol 1999;20:336-343 (Pubitemid 30418726)
8. Nakagawara J, Takeda R, Suematsu K, et al. Quantification of regional cerebral blood flow and vascular reserve in childhood moyamoya disease using [123I]IMP-ARG method. Clin Neurol Neurosurg 1997;99(suppl 2):S96-99 (Pubitemid 27489073)
9. Honda M, Ezaki Y, Kitagawa N, et al. Quantification of the regional cerebral blood flow and vascular reserve in moyamoya disease using split-dose iodo-amphetamine I 123 single-photon emission computed tomography. Surg Neurol 2006;66:155-159, discussion 159 (Pubitemid 44107428)
10. Hoshi H, Ohnishi T, Jinnouchi S, et al. Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT. J Nucl Med 1994;35:44-50 (Pubitemid 24018439)
11. Takeuchi R, Sengoku T, Matsumura K. Usefulness of fully automated constant ROI analysis software for the brain: 3DSRT and FineSRT. Radiat Med 2006;24:538-544
12. Takeuchi R. Fully automated ROI analysis software for the brain; 3DSRT [in Japanese]. Nippon Hoshasen Gijutsu Gakkai Zasshi 2003;59:1462-1474
13. Ohta T, Tanaka H, Kuroiwa T. Diffuse leptomeningeal enhancement, "ivy sign," in magnetic resonance images of moyamoya disease in childhood: case report. Neurosurgery 1995;37:1009-1012
14. Yoon HK, Shin HJ, Chang YW. "Ivy sign" in childhood moyamoya disease: depiction on FLAIR and contrast-enhanced T1-weighted MR images. Radiology 2002;223:384-389 (Pubitemid 34454314)
15. Suzuki J, Kodama N. Cerebrovascular "moyamoya" disease. 2: collateral routes to forebrain via ethmoid sinus and superior nasal meatus. Angiology 1971;22:223-236
16. Satoh S, Shibuya H, Matsushima Y, et al. Analysis of the angiographic findings in cases of childhood moyamoya disease. Neuroradiology 1988;30:111-119 (Pubitemid 18109028)
17. Yamada I, Murata Y, Umehara I, et al. SPECT and MRI evaluations of the posterior circulation in moyamoya disease. J Nucl Med 1996;37:1613-1617 (Pubitemid 26337161)
18. Mugikura S, Takahashi S, Higano S, et al. Predominant involvement of ipsilateral anterior and posterior circulations in moyamoya disease. Stroke 2002;33:1497-1500 (Pubitemid 34619946)
19. Settakis G, Molnar C, Kerenyi L, et al. Acetazolamide as a vasodilatory stimulus in cerebrovascular diseases and in conditions affecting the cerebral vasculature. Eur J Neurol 2003;10:609-620 (Pubitemid 38030869)
20. Fujimura M, Kaneta T, Mugikura S, et al. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 2007;67:273-282 (Pubitemid 46274903)
21. McAuley DJ, Poskitt K, Steinbok P. Predicting stroke risk in pediatric moyamoya disease with xenon-enhanced computed tomography. Neurosurgery 2004;55:327-32, discussion 332-333 (Pubitemid 39014519)
22. 2O positron emission tomography. Stroke 1995;26:1825-1829
23. Ito H, Inoue K, Goto K. Database of normal human cerebral blood flow measured by SPECT. I. Comparison between I-123-IMP, Tc-99m-HMPAO, and Tc-99m-ECD as referred with O-15 labeled water PET and voxel-based morphometry. Ann Nucl Med 2006;20:131-208
24. 2 changes in humans measured by positron emission tomography. J Cereb Blood Flow 2000;20:1264-1270